BackgroundAlcohol use disorder (AUD) is one of the most common substance use disorders globally. It is a chronic mental illness characterized by frequent relapses. Hence, preventing relapse is one of the most important aspects of the management of patients with AUD.
AimsThis study aimed to compare the role of acamprosate and baclofen as anti-craving agents in patients diagnosed with AUD.